CD8A and neoplasm: The role of IL-17-producing T cells in tumour immunity, however, is still controversial46; in mouse models, blocking IL-1747 and adoptive transfer of tumour-specific IL-17-producing CD8+ T cells48 have both demonstrated antitumoural effects.